相关实验视频
Updated: Jul 6, 2025
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
TrkA促进MDM2介导的AGPS无化和降解,从而触发前列腺癌的进展
Yu Zhang1,2,3, Zhenlin Huang1, Keqiang Li1,3
1Department of Urology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Journal of experimental & clinical cancer research : CR
|January 10, 2024
概括
这项研究表明,较低的AGPS蛋白水平与前列腺癌存活率差的相关性. 用抑制剂向TrkA可增强铁亡,为前列腺癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞死亡机制 细胞死亡机制
- 分子生物学分子生物学
背景情况:
- 铁亡,一种新的细胞死亡形式,与瘤的进展和治疗有关.
- 前列腺癌中铁亡的特定机制和过氧体的作用尚未完全理解.
- 这项研究确定了前列腺癌进展中的新型铁亡机制.
研究的目的:
- 阐明AGPS在铁亡和前列腺癌进展中的作用.
- 调查AGPS稳定性和功能的监管机制.
- 为了探索新的前列腺癌治疗策略,利用ferroptosis.
主要方法:
- 无标签的质谱测量用于识别涉及铁亡的蛋白质.
- 免疫组织化学评估前列腺癌组织中的AGPS表达.
- 同免疫沉和GST拉下测试以确定蛋白质相互作用.
- 细胞活力和殖民地形成测试以评估AGPS功能.
- 异种移植模型用于验证体内发现的结果.
- 西方涂抹和激酶抑制剂治疗以研究调节途径.
主要成果:
- 在前列腺癌中,AGPS蛋白表达的下调,与患者存活率较低相关.
- 通过调节过氧酶体功能,AGPS促进铁亡,减少前列腺癌细胞存活率.
- AGPS通过MDM2通过蛋白质体通路被ubiquitinated和降解.
- 酶TrkA在Y451酸化了AGPS,促进了AGPS-MDM2相互作用.
- 抑制TrkA增加了ferroptosis的易受性,并抑制了前列腺癌的扩散在体外和体内.
结论:
- AGPS在调节铁和前列腺癌进展方面发挥着至关重要的作用.
- TrkA-MDM2-AGPS轴是前列腺癌的一个关键调节途径.
- 将铁灭菌诱导剂与TrkA抑制剂结合起来,为前列腺癌治疗提供了一个协同的抗瘤策略.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:00Enzyme-linked Receptors
78.5K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K